Forced Vital Capacity (FVC) decline, mortality and healthcare resource utilization in idiopathic pulmonary fibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Forced Vital Capacity (FVC) decline, mortality and healthcare resource utilization in idiopathic pulmonary fibrosis

Published:2019-12-17 Issue:1 Volume:7 Page:1702618
ISSN:2001-8525
Container-title:European Clinical Respiratory Journal
language:en
Short-container-title:European Clinical Respiratory Journal

Author:

Lassenius Mariann I.¹,Toppila Iiro¹,Pöntynen Nora²,Kasslin Laura²,Kaunisto Jaana³,Kilpeläinen Maritta³,Laitinen Tarja⁴

Affiliation:

1. Medaffcon Oy, Espoo, Finland

2. Boehringer Ingelheim KY, Helsinki, Finland

3. Department of Pulmonary Diseases, Turku University Hospital and University of Turku, Turku, Finland

4. Hospital administration, Tampere University Hospital, Tampere, Finland

Funder

Boehringer Ingelheim

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/20018525.2019.1702618

Reference33 articles.

1. An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

2. Idiopathic pulmonary fibrosis

3. Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000;161:19.

4. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper

5. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computed tomography machine learning classifier correlates with mortality in interstitial lung disease;Respiratory Investigation;2024-07

2. Hospitalisation patterns in interstitial lung diseases: data from the EXCITING-ILD registry;Respiratory Research;2024-01-04

3. Clinical implications of frailty assessed in hospitalized patients with acute-exacerbation of interstitial lung disease;Chronic Respiratory Disease;2024-01

4. Historical eye on IPF: a cohort study redefining the mortality scenario;Frontiers in Medicine;2023-06-02

5. Economic Burden of Idiopathic Pulmonary Fibrosis in Spain: A Prospective Real-World Data Study (OASIS Study);PharmacoEconomics;2023-05-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3